Multiples slam funding deal as “unacceptable”
Multiples have slammed this year's contract funding agreement, warning that pharmacies will have to scale back their offerings and could even go out of business as a result of severe cuts.
The Co-operative Pharmacy called the deal a "disappointing result", Lloydspharmacy branded tariff reductions "unacceptable" and Day Lewis warned that the settlement would see pharmacy "doing more for less".
Businesses said they had serious concerns about their ability to continue to expand pharmacists' roles and may have to cut services.
The comments came after PSNC revealed the community pharmacy funding package for 2011-12, saying that it would reduce category M prices, introduce a specials tariff and increase practice payments under the deal.
Lloydspharmacy branded the tariff reductions unacceptable and pledged to raise the matter with the Department of Health. "No pharmacy contractor will have projected in their business plans for an impact of this size. The consequence could be the scaling back or stopping of services," said Lloydspharmacy managing director Tony Page. "We believe that it is possible that some community pharmacies will be forced to close," he added.
Rowlands Pharmacy managing director Kenny Black agreed that the settlement would have a "large impact on Rowlands and pharmacy as a whole". Rowlands would have to review some of its spending, he confirmed.
The Co-operative Pharmacy, Numark, Avicenna, Alliance Healthcare and pharmacists posting on C+D's website also raised concerns about the deal. "I think we are fast approaching a crisis point for community pharmacy," said Alliance Healthcare chair Mike Smith.
And the settlement was at odds with claims by health ministers that they expected pharmacy's role in healthcare provision to expand, some argued. "We are told by the government that businesses must invest in the future to help the economy grow, but community pharmacy needs more certainty in the baseline model for service than the current system delivers," said Pharmacy Voice chief executive Rob Darracott.
PSNC said this year's negotiations had been "difficult" given the economic climate. And this year's funding was always going to see "blood on the pharmacy floor", agreed Kirit Patel, managing director of Day Lewis.
A DH spokesperson told C+D: "A funding package of £2.526 billion was agreed for 2011/12 - an increase of £40 million on the funding package for 2010/11. On top of this, we are investing up to £55m in the New Medicine Service in 2011/12 and 2012/13."
Please note You must be a registered user of Chemist+Druggist and logged in to add comments. Opinions expressed here are those of the writers and do not necessarily reflect those of Chemist+Druggist. Comments are considered in the public domain and may be used in future Chemist+Druggist coverage. We accept no responsibility, legal or otherwise, for the accuracy or the content of member comments.



